Palla Pharma Limited (ASX:PAL)

Giles Moss
Market Cap (AUD): 47.76M
Sector: Health Care
Last Trade (AUD): 0.295 +0 (+0%)
Tab Bar

1. About

Palla Pharma Ltd (ASX:PAL) manufactures Narcotic Raw Material (NRM), Active Pharmaceuticals Ingredients (API) and Finished Dosage form Products (FDF).

Palla Pharma is one of three licensed poppy processors in Australia. It is one of six licensed NRM producers globally and one of only three fully integrated suppliers of opiates from NRM, API through to FDF products. The Company’s expansion within Australia and Europe includes the introduction of new growing areas to ensure long term sustainability for the supply of raw materials to meet customer requirements.

Palla Pharma has developed an innovative, efficient and environmentally-sustainable extraction and purification manufacturing process and has adopted industry best practice across every facet of its operations.

Palla Pharma’s experienced and highly skilled team provides the Company with its greatest commercial advantage, drawing on extensive industry and commercial experience.

Forging strong relationships is at the heart of Palla Pharma's business philosophy. From the farmer to customer delivery, the team understands the value of maintaining a personal approach to its partnerships. The Company delivers a highly competitive pricing platform made possible by its innovative growing and manufacturing practices.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk